Search only accepts letters and numbers.
Home
|
Advertising
|
Membership
|
Newsletters
|
Contact Us
|
About
|
BPC News
|
Submit Releases
|
Log Out
PREVIOUS ISSUES
NEWS BY INDUSTRY
Coronavirus
All Latest News
Banking & Finance
BPC News Releases
Business Community Events
Business Record E-newsletters
Business Record Insider
Culture
Economic Development
Energy & Environment
Health & Wellness
HR & Education
Insurance & Investments
Iowa News
Iowa Stops Hunger
Law & Government
Lift IOWA
Manufacturing & Logistics
On The Move
On the Record
Opinion
Real Estate & Development
Retail & Business
Sales & Marketing
Tech & Innovation
The Insider Notebook
Transportation
SPECIALTY PRODUCTS
Annual Real Estate Magazine
Best of Des Moines
Book of Lists
BPC Book Publishing
Business Insights
Custom Publishing
Development Guides
Fearless e-newsletter
Greater
innovationIOWA
Iowa Stops Hunger
Made in Iowa
Newcomer's Guide
Pillars of Philanthropy
Special Advertising Sections
Made in Iowa
EVENTS
Buy Tickets
Upcoming Business Record Events
Fearless Fridays
Book of Lists Unveiling Party
Power Breakfast
innovationIOWA unveiling
Women of Influence
Economic Forecast
Legislative Forecast
Commercial Real Estate Forum
Forty Under 40
90 ideas in 90 minutes
AWARDS
HR Exec. of the Year
Forty Under 40
Forty Under 40 Alumnus
CRE Pro of the Year
InnovationIOWA Awards
Women of Influence
CFO of the Year
CALENDAR
EXECUTIVE TOOLS
Public Notices
Reprints of Business Record
Request Rate Card
RSS Feeds
Video
New
Kemin enters exclusive agreement to license Eimeria vaccine for poultry
BY BUSINESS RECORD STAFF
Monday, October 19, 2020 10:44 AM
Kemin Industries, a global ingredient manufacturer based in Des Moines, with its subsidiary Kemin Biologics,
has signed an exclusive agreement
with Pacific GeneTech to license PGT's TMH001 Eimeria vaccine for poultry. PGT is a biologics company that develops and commercializes next-generation vaccines for areas of high unmet or underserved needs in animal health and food safety. As part of its partnership with PGT, Kemin will focus on developing the Eimeria vaccine and registering it in the United States and in other countries, beginning with the European Union. Kemin will also expand the Eimeria vaccine's availability to Asia, the Middle East, Africa and Latin America. Eimeria is an intestinal parasite that can infect poultry. "Kemin sees great potential in the marketplace for innovative vaccines and is dedicated to improving the health of poultry and livestock, which ensures the safety of our global food supply," said Chris Nelson, president and CEO of Kemin Industries. "This new agreement with Pacific GeneTech continues our advancement in providing next-generation vaccines that have the ability to transform the quality of life around the world."
X
Most Viewed
Most Commented
Woodley named president and CEO of Make-A-Wish Iowa
NOTABLE TRANSACTIONS: Sportsman's Warehouse property in Ankeny sold
Top 25 Most Influential Business Leaders in 2021 announced
$16.9 million historic renovation planned for Grand Tree Apartments in Des Moines
New exterior design for Hy-Vee grocery stores revealed; new Grimes store will include nail salon
Home
|
Advertising
|
Membership
|
Newsletters
|
Contact Us
|
About
|
BPC News
|
Submit Releases
|
Log Out
Facebook
Twitter
RSS
The Depot at 4th, 100 4th Street, Des Moines, Iowa 50309
|
(515) 288-3336
|
© 2021 Business Record. All Rights Reserved. |
Legal disclaimer
|
Privacy Policy
Software © 2021
1up! Software,
All Rights Reserved
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##